Medicare Drug Price Negotiation Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Oct 26, 2017)
Medicare Drug Price Negotiation Act
This bill makes a series of changes relating to the prices of prescription drugs under the Medicare prescription drug benefit and Medicare Advantage prescription drug plans, including requirements relating to rebates for low-income individuals and drug price negotiations.
What just happenedOct 27, 2017
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseOct 26, 2017
- Oct 27, 2017Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Oct 26, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Oct 26, 2017IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Oct 26, 2017IntroReferralIntro-H
Introduced in House
- Oct 26, 2017IntroReferral1000
Introduced in House